These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 37503751)

  • 21. Serum thymic stromal lymphopoietin (TSLP) levels in atopic dermatitis patients: a systematic review and meta-analysis.
    García-Reyes MM; Zumaya-Pérez LC; Pastelin-Palacios R; Moreno-Eutimio MA
    Clin Exp Med; 2023 Dec; 23(8):4129-4139. PubMed ID: 37515689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and treatment patterns of adult atopic dermatitis in the UK Clinical Practice Research Datalink.
    Kleyn CE; McKenzie R; Meeks A; Gittens B; von Arx LB
    Skin Health Dis; 2023 Aug; 3(4):e232. PubMed ID: 37538337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of Janus kinase signaling in the pathology of atopic dermatitis.
    Guttman-Yassky E; Irvine AD; Brunner PM; Kim BS; Boguniewicz M; Parmentier J; Platt AM; Kabashima K
    J Allergy Clin Immunol; 2023 Dec; 152(6):1394-1404. PubMed ID: 37536511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of tralokinumab in the treatment of atopic dermatitis: A systematic review and meta-analysis of randomized controlled trials.
    Zhao DJ; Huang LM; Xiao J; Chen L; Li X; Lin HX
    Medicine (Baltimore); 2023 Aug; 102(31):e34516. PubMed ID: 37543792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obsessive compulsive symptoms in mothers of children with atopic dermatitis.
    Celik V; Beken B; Gorker I; Ozdemir PG; Sut N; Yazicioglu M
    Postepy Dermatol Alergol; 2023 Jun; 40(3):411-415. PubMed ID: 37545829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hair repigmentation and regrowth in a dupilumab-treated paediatric patient with alopecia areata and atopic dermatitis: a case report.
    Yan X; Tayier M; Cheang ST; Liao Z; Dong Y; Yang Y; Ye Y; Zhang X
    Ther Adv Chronic Dis; 2023; 14():20406223231191049. PubMed ID: 37546700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomized double-blinded placebo-controlled DUPISTAD study.
    Merola JF; Chiou AS; During E; Costanzo A; Foley P; Alfalasi A; Gogate S; Pinter A; Dodiuk-Gad R; Simon D; Tauber M; Weller R; Pereyra-Rodriguez JJ; Ardeleanu M; Wu J; Ozturk ZE
    Br J Dermatol; 2023 Nov; 189(6):685-694. PubMed ID: 37562034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-life effects of dupilumab on airway oscillometry in severe uncontrolled asthma.
    Chan R; Lipworth B
    Ann Allergy Asthma Immunol; 2023 Nov; 131(5):664-666. PubMed ID: 37517659
    [No Abstract]   [Full Text] [Related]  

  • 29. Epidermal biomarkers of the skin barrier in atopic and contact dermatitis.
    de Boer FL; van der Molen HF; Kezic S
    Contact Dermatitis; 2023 Oct; 89(4):221-229. PubMed ID: 37571977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of excessive daytime sleepiness among patients with atopic dermatitis.
    Halioua B; Taieb J; Seneschal J; Corgibet F; Misery L; Marquié A; Merhand S; Staumont-Salle D; Ezzedine K; Taieb C; Richard MA
    Skin Health Dis; 2023 Aug; 3(4):e227. PubMed ID: 37538318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Action plans for atopic dermatitis: A survey of patient and caregiver attitudes.
    Johnson JK; Loiselle AR; Butler L; Begolka WS
    JAAD Int; 2023 Sep; 12():184-185. PubMed ID: 37538370
    [No Abstract]   [Full Text] [Related]  

  • 32. Dupilumab therapy in children aged 2-12 years with uncontrolled moderate-to-severe atopic dermatitis: A Chinese real-world study.
    Zhou B; Peng C; Cao Q; Wang J; Chen X; Li J
    J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):e35-e38. PubMed ID: 37565387
    [No Abstract]   [Full Text] [Related]  

  • 33. Anti-interleukin 4 receptor α antibody for the treatment of Chinese bullous pemphigoid patients with diverse comorbidities and a 1-year follow-up: a monocentric real-world study.
    Wang SH; Shan Y; Li SZ; Zuo YG
    Front Immunol; 2023; 14():1165106. PubMed ID: 37545503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Burden of Disease and Unmet Needs in the Diagnosis and Management of Atopic Dermatitis in the Arabic Population of the Middle East.
    Mahmoud O; Yosipovitch G; Attia E
    J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Candidate Gene Association Studies in Atopic Dermatitis in Participants of European and Asian Ancestry: A Systematic Review and Meta-Analysis.
    Pontikas A; Antonatos C; Evangelou E; Vasilopoulos Y
    Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of distinct gene co-expression modules and specific hub genes in skin lesions of atopic dermatitis and psoriasis by WGCNA.
    Sheng Y; Liu J; Zheng S
    FEBS Open Bio; 2023 Oct; 13(10):1887-1894. PubMed ID: 37548115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amino Acid Profiling Identifies Disease-Specific Signatures in IgE-Mediated and Non-IgE-Mediated Food Allergy in Pediatric Patients with Atopic Dermatitis.
    Packi K; Matysiak J; Plewa S; Klupczyńska-Gabryszak A; Matuszewska E; Rzetecka N; Bręborowicz A; Matysiak J
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-world severe asthma biologic administration and adherence differs by biologic: CHRONICLE study results.
    Ledford DK; Soong W; Carr W; Trevor J; Tan L; Carstens D; Ambrose CS
    Ann Allergy Asthma Immunol; 2023 Nov; 131(5):598-605.e3. PubMed ID: 37506846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dupilumab-induced eosinophilia in patients with diffuse type 2 chronic rhinosinusitis.
    Ryser FS; Yalamanoglu A; Valaperti A; Brühlmann C; Mauthe T; Traidl S; Soyka MB; Steiner UC
    Allergy; 2023 Oct; 78(10):2712-2723. PubMed ID: 37548395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tralokinumab Effectively Disrupts the IL-13/IL-13Rα1/IL-4Rα Signaling Complex but Not the IL-13/IL-13Rα2 Complex.
    Tollenaere MAX; Mølck C; Henderson I; Pollack S; Addis P; Petersen HH; Norsgaard H
    JID Innov; 2023 Sep; 3(5):100214. PubMed ID: 37554517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.